导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 54.87% | 30/1050 |
| 近一周 | -3.77% | 939/1104 |
| 近一月 | 1.43% | 40/1102 |
| 近一季 | -10.53% | 683/1092 |
| 近半年 | 44.38% | 24/1070 |
| 近一年 | 79.86% | 13/1018 |
| 近两年 | 295.78% | 12/926 |
| 近三年 | 209.76% | 16/834 |
| 成立以来 | 292.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.77% 71/1070 |
77.10% 123/1101 |
- - |
- - |
| 2025 | 94.05% 16/1065 |
0.91% 728/1014 |
11.06% 80/1038 |
59.77% 41/1050 |
8.38% 66/1065 |
| 2024 | 5.05% 423/1011 |
-8.09% 702/960 |
2.55% 170/983 |
9.74% 637/991 |
1.56% 253/1011 |
| 2023 | -18.28% 631/952 |
7.12% 214/880 |
-2.33% 324/895 |
-19.93% 863/915 |
-2.46% 267/952 |
| 2022 | -35.05% 702/867 |
-23.07% 670/773 |
1.97% 664/806 |
-20.13% 756/845 |
3.66% 256/867 |
| 2021 | 1.99% 335/740 |
-19.49% 551/580 |
30.54% 52/659 |
-5.18% 362/704 |
2.36% 340/740 |
| 2020 | 46.19% 260/554 |
3.17% 93/419 |
39.73% 27/466 |
0.07% 418/517 |
1.33% 478/554 |
| 2019 | 68.45% 46/410 |
37.64% 97/1149 |
-8.71% 947/1231 |
17.00% 28/390 |
14.58% 60/410 |
| 2018 | -31.82% 244/349 |
- - |
- - |
- - |
-9.38% 248/1080 |
| 2017 | 1.05% 176/285 |
- - |
- - |
- - |
- - |
| 2016 | -24.42% 135/205 |
- - |
- - |
- - |
- - |
| 2015 | 80.14% 6/151 |
- - |
- - |
- - |
- - |
| 2014 | 4.61% 21/24 |
- - |
- - |
- - |
- - |
| 2013 | 48.67% 1/21 |
- - |
- - |
- - |
- - |
| 2012 | 5.14% 83/157 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信科技先锋股票 VS. 东吴新产业精选股票A(580008) |